Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Cost of Goods Sold

Alexion Pharm Inc Cost of Goods Sold Chart (ALXN)

Alexion Pharm Inc annual/quarterly Cost of Goods Sold from 2010 to 2020.
  • Alexion Pharm Inc Cost of Goods Sold for the quarter ending September 09, 2020 was $145m a 21.01% increase of 30m year over year
  • Alexion Pharm Inc Cost of Goods Sold for the last 12 months ending September 09, 2020 was $516m a 23.49% increase of 121m year over year
  • Alexion Pharm Inc Annual Cost of Goods Sold for 2019 was $395m a 6.59% increase of 26m from 2018
  • Alexion Pharm Inc Annual Cost of Goods Sold for 2018 was $369m a 18.02% increase of 66m from 2017
  • Alexion Pharm Inc Annual Cost of Goods Sold for 2017 was $302m a 14.50% increase of 44m from 2016
Other Income Statement Metrics:
  • Alexion Pharm Inc EBITDA for the quarter ending December 12, 2018 was $533m a 18.12% increase of 97m year over year
  • Alexion Pharm Inc Net Income for the quarter ending December 12, 2018 was $-45m a 653.56% decrease of -294m year over year
  • Alexion Pharm Inc Total Revenue for the quarter ending December 12, 2018 was $1,129m a 17.53% increase of 198m year over year
View Chart On Koyfin

Quarterly ALXN Cost of Goods Sold Data

09/2020$145m
06/2020$145m
03/2020$112m
12/2019$114m
09/2019$95m
06/2019$99m
03/2019$86m
12/2018$97m
09/2018$91m
06/2018$95m

Annual ALXN Cost of Goods Sold Data

2019$395m
2018$369m
2017$302m
2016$258m
2015$233m
2014$174m
2013$168m
2012$126m
2011$93m
2010$64m